Cargando…
Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control
Leishmaniasis is a neglected tropical parasitic disease with few approved medications. Cutaneous leishmaniasis (CL) is the most frequent form, responsible for 0.7 - 1.0 million new cases annually worldwide. Leukotrienes are lipid mediators of inflammation produced in response to cell damage or infec...
Autores principales: | Noronha, Letícia Paula Trajano, Martins, Monique Daiane Andrade, Castro-Junior, Archimedes Barbosa, Thorstenberg, Maria Luiza, Costa-Soares, Laís, Rangel, Thuany Prado, Carvalho-Gondim, Felipe, Rossi-Bergmann, Bartira, Savio, Luiz Eduardo Baggio, Canetti, Claudio de Azevedo, Coutinho-Silva, Robson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291179/ https://www.ncbi.nlm.nih.gov/pubmed/37377641 http://dx.doi.org/10.3389/fcimb.2023.1192800 |
Ejemplares similares
-
Purinergic Cooperation Between P2Y(2) and P2X7 Receptors Promote Cutaneous Leishmaniasis Control: Involvement of Pannexin-1 and Leukotrienes
por: Thorstenberg, Maria Luiza, et al.
Publicado: (2018) -
Non-canonical NLRP3 inflammasome activation and IL-1β signaling are necessary to L. amazonensis control mediated by P2X7 receptor and leukotriene B(4)
por: Chaves, Mariana M., et al.
Publicado: (2019) -
Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021) -
Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts
por: Kanaoka, Yoshihide, et al.
Publicado: (2014) -
Adipokines and Cysteinyl Leukotrienes in the Pathogenesis of Asthma
por: Coffey, Michael J., et al.
Publicado: (2015)